Indiana University Melvin and Bren Simon Comprehensive Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center has participated in 60 clinical trials with 39 currently active.
Therapeutic areas: Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma.
Sponsors: Roswell Park Cancer Institute, Bryan Schneider, MD, Jeffrey Clarke.
Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center has 60 clinical trials on record, with 39 currently active. Their work covers Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma.
Yes — Indiana University Melvin and Bren Simon Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.